Semaglutide is currently being investigated in two large phase III clinical trial programs for treating obesity: the STEP program, which aims to obtain regulatory approval for semaglutide as an anti-obesity drug and is evaluating cardiovascular outcomes in 17,500 patients
The 0.5mL option works if you have a high-quality syringe with clear markings at the 10-unit level, but cheaper syringes can make that small volume harder to measure accurately
Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new report from Pharmaceutical Strategies Group (PSG) found
Retrieved from Bezin, J., Gouverneur, A., Pnichon, M., et al
Compounded semaglutide is not FDA-approved, and this blog does not constitute medical advice
Retatrutide works best with consistent weekly timing